3D-ARM (3D ultrasound Assessment in Recurrent Miscarriage)

  • Research type

    Research Study

  • Full title

    Association of Acquired uterine abnormalities with recurrent miscarriage

  • IRAS ID

    330231

  • Contact name

    Kanna Jayaprakasan

  • Contact email

    kanna.jayaprakasan@nhs.net

  • Sponsor organisation

    Research & Development Department,University Hospitals of Derby and Burton

  • Duration of Study in the UK

    1 years, 11 months, 31 days

  • Research summary

    Recurrent miscarriage (RM) is the loss of two or more pregnancies before 24 weeks of gestation. It affects 1-3% of women trying to conceive and is associated with significant physical and psychological consequences to those affected. Couples referred to RM undergo investigations including pelvic scan. While two-thirds of the causes of RM are unexplained, congenital (present from birth) uterine abnormalities could be linked with miscarriages. However, there is lack of definite evidence whether acquired (developed after birth) uterine abnormalities are linked to RM and the recent draft guideline from the RCOG recommended doing research on this. This study proposes to see whether uterine abnormalities like fibroids, polyps, scar tissues inside the uterus or adenomyosis (presence of lining of the womb with in the uterine muscles) are more commonly seen in RM patients (study group) than in the fertile background population (control group). All women will have a 3D ultrasound, which is more accurate than 2D scan in diagnosing uterine abnormalities. The proportion of women with abnormalities of uterus between the groups will be compared. This comparison will help to establish whether there is a link between acquired uterine abnormalities and RM and if proven, further studies can be looked at treating those abnormalities would help to reduce the chances of further miscarriages.

  • REC name

    South West - Cornwall & Plymouth Research Ethics Committee

  • REC reference

    23/SW/0130

  • Date of REC Opinion

    10 Nov 2023

  • REC opinion

    Further Information Favourable Opinion